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INTRODUCTION 
Spermatogonial stem cells (SSCs) form the foundation of 
fertility throughout the life of the adult male. However, 
pathways controlling their self-renewal versus differentiation 
remain poorly understood. It has previously been established 
that the deubiquinating enzyme Ubiquitin Carboxyl-Terminal 
Hydrolase 1 (UCH-L1) is specifically expressed in 
undifferentiated spermatogonia that contain the SSC 
population [1]. Based on previous observations that UCH-L1 
expression decreases with germ-line differentiation, it is 
hypothesized that UCH-L1 may play a role in SSC 
maintenance. The overall goal of the project is to elucidate the 
role of UCH-L1 in an immortalized type A spermatogonia 
mouse cell line.  
METHODS 
This project uses C18-4 cells [2], an immortalized type A 
mouse spermatogonia cell line, treated with a specific, 
reversible, active site directed inhibitor of UCH-L1 to examine 
the growth characteristics of germ cells in the absence of 
UCH-L1 activity. Cells were treated with 5µM, 10µM and 
20µM of UCH-L1 inhibitor compared to DMSO (vehicle) and 
no treatment control for 24 and 48 hours. Changes in cell 
number, viability, proliferation (EdU), and apoptosis 
(TUNEL) were assessed between treatments. 
RESULTS 
A decreasing trend of cell number and proliferation was 
observed with increasing UCH-L1 inhibitor concentration. 
The greatest change in cell number was observed in the 48-
hour treatment group with 20µM of UCH-L1 inhibitor 
(p=0.0659) (Figure 1). There was no change observed in 
TUNEL or cell viability. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 48-hour treatment of C18-4 cells with UCH-L1 
inhibitor. The treatment groups are plotted against the average 
cell number with standard deviation bars (n=2). 
DISCUSSION AND CONCLUSIONS 
Results analyzed to date show no significant differences 
between treatments, which is likely due to low replicate 
number (n=2).  However, a trend of decreasing cell number 
and proliferation was observed with increasing UCH-L1 
inhibitor concentration for both 24 hour and 48-hour 
treatments.  Results of these experiments will help determine 
the appropriate inhibitor treatment to further examine the 
mechanistic actions of UCH-L1. Furthermore, elucidating this 
pathway may lead to new strategies to support expansion of 
SSCs in vitro. 
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